Cancer Immunotherapy intermediate
Checkpoint Inhibitor B7-H4-VTCN
Reference for checkpoint inhibitor B7-H4-VTCN in peptide research.
By Encyclopeptide Editorial | 1 min read
checkpoint-inhibitor B7-H4-VTCN checkpoint inhibitor cancer-immunotherapy
Overview
checkpoint inhibitor B7-H4-VTCN is a peptide studied in cancer immunotherapy research.
Properties
| Property | Value |
|---|---|
| Parent | checkpoint-inhibitor |
| Variant | B7-H4-VTCN |
| Type | Checkpoint inhibitor |
| Category | Cancer Immunotherapy |
Significance
This checkpoint inhibitor has been investigated for its biological activity and therapeutic potential.
References
- Encyclopeptide Database. “checkpoint-inhibitor-B7-H4-VTCN” monograph. encyclopeptide.com.
Chemical Identity
| Property | Value |
|---|---|
| Name | Checkpoint Inhibitor B7-H4-VTCN |
| Category | Cancer Immunotherapy |
Test Your Knowledge
Reinforce what you learned about Checkpoint Inhibitor B7-H4-VTCN with interactive quizzes on Wikipept.
Take a Quiz on Wikipept